CaLycia Bioscience is a biotechnology startup that develops myeloid-based cell therapy for treating tumors such as glioblastoma.
CaLycia Bioscience has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2026.
CaLycia Bioscience's investors include EPIC Ventures, Cumming Capital Management.
CaLycia Bioscience is headquartered in Salt Lake City, United States.
CaLycia Bioscience is a biotechnology startup that develops myeloid-based cell therapy for treating tumors such as glioblastoma.
CaLycia Bioscience is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CaLycia Bioscience — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/calycia-bioscience. Accessed August 14, 2026.
VCBacked. (2026). CaLycia Bioscience — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/calycia-bioscience
{{cite web |title=CaLycia Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/calycia-bioscience |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated